CLINICAL_TRIALS
trial_result
· 2016-10-17
Clinical Trial Update: Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1) [Phase 1]
Summary
A Phase 1 study comparing two oral formulations of nitisinone for hereditary tyrosinemia type I completed, with bioequivalence results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cycle Pharmaceuticals Ltd. | Conditions: Hereditary Tyrosinemia, Type I | Phase 1 | Status: COMPLETED | Results posted: 2016-10-17